These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 10068150
1. The effect of toremifene on bone and uterine histology and on bone resorption in ovariectomised rats. Karlsson S, Mäntylä E, Hirsimäki Y, Niemi S, Nieminen L, Nieminen K, Kangas L. Pharmacol Toxicol; 1999 Feb; 84(2):72-80. PubMed ID: 10068150 [Abstract] [Full Text] [Related]
2. Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats. Qu Q, Zheng H, Dahllund J, Laine A, Cockcroft N, Peng Z, Koskinen M, Hemminki K, Kangas L, Väänänen K, Härkönen P. Endocrinology; 2000 Feb; 141(2):809-20. PubMed ID: 10650964 [Abstract] [Full Text] [Related]
3. Antiosteoporotic activity of echinacoside in ovariectomized rats. Li F, Yang X, Yang Y, Guo C, Zhang C, Yang Z, Li P. Phytomedicine; 2013 Apr 15; 20(6):549-57. PubMed ID: 23428402 [Abstract] [Full Text] [Related]
4. Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: effects of raloxifene HCl, tamoxifen, estrogen, and alendronate. Frolik CA, Bryant HU, Black EC, Magee DE, Chandrasekhar S. Bone; 1996 Jun 15; 18(6):621-7. PubMed ID: 8806005 [Abstract] [Full Text] [Related]
5. Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model. Ke HZ, Chen HK, Simmons HA, Qi H, Crawford DT, Pirie CM, Chidsey-Frink KL, Ma YF, Jee WS, Thompson DD. Bone; 1997 Jan 15; 20(1):31-9. PubMed ID: 8988345 [Abstract] [Full Text] [Related]
6. Comparisons of the effects of tamoxifen, toremifene and raloxifene on enzyme induction and gene expression in the ovariectomised rat uterus. Green AR, Parrott EL, Butterworth M, Jones PS, Greaves P, White IN. J Endocrinol; 2001 Sep 15; 170(3):555-64. PubMed ID: 11524235 [Abstract] [Full Text] [Related]
7. Protective effects of sodium daidzein sulfonate on trabecular bone in ovariectomized rats. Ren P, Ji H, Shao Q, Chen X, Han J, Sun Y. Pharmacology; 2007 Sep 15; 79(3):129-36. PubMed ID: 17179740 [Abstract] [Full Text] [Related]
8. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats. Ke HZ, Simmons HA, Pirie CM, Crawford DT, Thompson DD. Endocrinology; 1995 Jun 15; 136(6):2435-41. PubMed ID: 7750465 [Abstract] [Full Text] [Related]
9. The binding of [3H]-oestradiol-17 beta in the immature rat uterus during the sequential administration of non-steroidal anti-oestrogens. Jordan VC, Naylor KE. Br J Pharmacol; 1979 Feb 15; 65(2):167-73. PubMed ID: 760895 [Abstract] [Full Text] [Related]
10. Chronic effects of toremifene on the vasculature of menopause-induced rats. González-Pérez J, Crespo MJ. Vascul Pharmacol; 2003 Dec 15; 40(5):261-8. PubMed ID: 15259793 [Abstract] [Full Text] [Related]
11. Compartmentalized uterotrophic effects of tamoxifen, toremifene, and estradiol in the ovariectomized Wistar (Han) rat. Carthew P, Edwards RE, Nolan BM, Tucker MJ, Smith LL. Toxicol Sci; 1999 Apr 15; 48(2):197-205. PubMed ID: 10353311 [Abstract] [Full Text] [Related]
12. Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats. Ke HZ, Chen HK, Qi H, Pirie CM, Simmons HA, Ma YF, Jee WS, Thompson DD. Bone; 1995 Nov 15; 17(5):491-6. PubMed ID: 8579962 [Abstract] [Full Text] [Related]
13. Prophylactic effects of 1,24,25-trihydroxyvitamin D3 on ovariectomy-induced cancellous bone loss in the rat. Erben RG, Bante U, Birner H, Stangassinger M. Calcif Tissue Int; 1997 May 15; 60(5):434-40. PubMed ID: 9115161 [Abstract] [Full Text] [Related]
14. Long-term sensitivity of uterus and hypothalamus/pituitary axis to 17beta-estradiol is higher than that of bone in rats. Erben RG, Brunner KS, Breig B. J Bone Miner Res; 2004 Nov 15; 19(11):1827-32. PubMed ID: 15476583 [Abstract] [Full Text] [Related]
15. Comparing the effects of atamestane, toremifene and tamoxifen alone and in combination, on bone, serum lipids and uterus in ovariectomized rats. Goss PE, Qi S, Hu H. J Steroid Biochem Mol Biol; 2009 Feb 15; 113(3-5):233-40. PubMed ID: 19429427 [Abstract] [Full Text] [Related]
16. Effects of toremifene on neonatal rat uterine growth and differentiation. Medlock KL, Branham WS, Sheehan DM. Biol Reprod; 1997 May 15; 56(5):1239-44. PubMed ID: 9160724 [Abstract] [Full Text] [Related]
17. Comparison of effects of tamoxifen and toremifene on bone biochemistry and bone mineral density in postmenopausal breast cancer patients. Marttunen MB, Hietanen P, Tiitinen A, Ylikorkala O. J Clin Endocrinol Metab; 1998 Apr 15; 83(4):1158-62. PubMed ID: 9543133 [Abstract] [Full Text] [Related]
18. Effect of oestrogen receptor alpha and beta agonists on brain N-methyl-D-aspartate receptors. Morissette M, Le Saux M, Di Paolo T. J Neuroendocrinol; 2008 Aug 15; 20(8):1006-14. PubMed ID: 18510708 [Abstract] [Full Text] [Related]
19. The effects of clodronate on increased bone turnover and bone loss due to ovariectomy in rats. Kippo K, Hannuniemi R, Virtamo T, Laurén L, Ikävalko H, Kovanen V, Osterman T, Sellman R. Bone; 1995 Dec 15; 17(6):533-42. PubMed ID: 8835307 [Abstract] [Full Text] [Related]
20. Isoformononetin, a methoxydaidzein present in medicinal plants, reverses bone loss in osteopenic rats and exerts bone anabolic action by preventing osteoblast apoptosis. Srivastava K, Tyagi AM, Khan K, Dixit M, Lahiri S, Kumar A, Changkija B, Khan MP, Nagar GK, Yadav DK, Maurya R, Singh SP, Jain GK, Wahajuddin, Trivedi R, Chattopadhyay N, Singh D. Phytomedicine; 2013 Apr 15; 20(6):470-80. PubMed ID: 23395215 [Abstract] [Full Text] [Related] Page: [Next] [New Search]